Stereotaxis (STXS) received U.S. Food and Drug Administration 510(k) clearance for its MAGiC Sweep catheter. The company said, “MAGiC Sweep is the world’s first robotically navigated high-density electrophysiology mapping catheter, representing a significant advancement in the technology available to diagnose and treat complex arrhythmia patients.”
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STXS:
